Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

SEC Filing Details

Document Details

Filing Date
Mar 14, 2023
Document Date
Mar 14, 2023
Form Description
UPLOAD
Filing Group
Other
Company
Homology Medicines, Inc.
Issuer
Homology Medicines, Inc.